Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

SuperCom Ltd. (NASDAQ: SPCB) EM Tracking Increasingly Seen as Key to Successfully Addressing Domestic Violence

Electronic monitoring technology developer SuperCom (NASDAQ: SPCB) provides products and services that help clients track people under their supervision. Its solutions are primarily used by police and court agencies to monitor the movements of individuals released pretrial, on probation after conviction, or on parole following incarceration. Concerns about the incidence of domestic violence are increasingly […]

EXECUTIVE REPORT: 4th INVESTIGATOR-INITIATED TRIALS SUMMIT

Dynamic Global Events (“DGE”) recently hosted the Investigator-Initiated Trials (“IIT”) Conference, gathering industry experts, clinical investigators and research professionals for an immersive two-day event focused on advancing investigator-initiated trials. This year’s event provided an in-depth look into the challenges, best practices and regulatory considerations essential to optimizing IIT processes in today’s rapidly evolving clinical research […]

SuperCom Ltd. (NASDAQ: SPCB) Conference Presentation Focuses on Lives Saved Through EM Technology and Services

Governments worldwide are turning to electronic monitoring (“EM”) solutions as a means of sustaining public safety and reducing repeat criminal behavior while also reducing the costs associated with imprisoning individuals — a trend outlined by EM innovator SuperCom (NASDAQ: SPCB) at a recent investor LD Micro presentation. SuperCom President and CEO Ordan Trabelsi explained the competitive […]

Kairos Pharma Ltd. (NYSE: KAPA) Developing Innovative Therapies to Tackle Cancer Drug Resistance, Immune Suppression

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, is dedicated to advancing innovative oncology therapies to overcome critical challenges in cancer drug resistance and immune suppression, two significant challenges to effective cancer treatment. With an extensive intellectual property portfolio valid until 2035 to 2040, the company is developing a notable pipeline of drugs tackling […]

EXECUTIVE REPORT: 5TH NEXT-GEN MSL EXCELLENCE SUMMIT

Dynamic Global Events recently concluded the 5th Next-Gen MSL Excellence conference, a premier event that brought together MSLs, field medical professionals and industry thought leaders to explore the best ways to grow “soft skills” and maintain productive KOL relationships. This engaging event highlighted innovative strategies, skills development and cutting-edge technologies that are shaping the future […]

D-Wave Quantum Inc. (NYSE: QBTS) Advances Quantum Computing with Enhanced 4,400+ Qubit Advantage2(TM) Processor

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has achieved a significant milestone in the ongoing development of its sixth-generation annealing quantum computing system by completing the calibration and benchmarking of a 4,400+ qubit Advantage2 processor (https://ibn.fm/SEoTd). The Advantage2 processor has shown substantial […]

AI is Helping to Ease the Job Application Process

Several companies are touting novel artificial intelligence technologies that promise to revolutionize the job-search process. This development has emerged at a time when the rate at which people are looking for new jobs has reached very high levels. For example, data reveals that at least 28% of U.S. residents were recently job-hunting. Jeff, a well-followed TikTok user, emphasized that […]

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform

The American Cancer Society (“ACA”) has projected that 2024 will be the first year ever to see two million people diagnosed with cancer, which remains the second leading cause of death in the United States, after heart disease (https://ibn.fm/ADo2Q). Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are working hard to discover more effective treatments […]

 

From Our Blog

Why 2026 Is a Pivotal Year for Private, Pre-IPO, and Microcap Investing, and What That Means for DealFlow Discovery

January 23, 2026

As we head into January 2026, the capital markets landscape is in a period of subtle but consequential transition, one that has real implications for the direction of private company financings, pre-public valuations, and the small-cap ecosystem that DealFlow Discovery Conference now reflects. For years, microcap investing sat at the intersection of retail enthusiasm and […]

Rotate your device 90° to view site.